NU643 FINAL EXAM STUDY QUESTIONS WITH CORRECT ANSWERS 2025

NU643 FINAL EXAM STUDY QUESTIONS
WITH CORRECT ANSWERS 2025
1.AQCommonQsideQeffectsQaboutQantidepressantsQ-QcorrectQanswerQ-
dryQmouthQsexualQdysfunctionQdizzinessQdecreasedQorQincreasedQappetiteQdrowsinessQheadacheQfatigueQ
giQupsetQ(nausea)sleepQdisturbance



2.QManagingQbehavioralQandQpsychologicalQsymptomsQofQdementiaQreviewQhabilitationQtherapyQ-
QcorrectQanswerQ-keepingQroutine,QcalmQatmosphereQmaintainQfunctionQtheyQhaveQatQthisQtime—

cueQintoQbehaviorsQtheyQcanQdoQnowQ(habilitationQtherapy)behavioralQsxQforQdementiaQaggressionQagiata
tionQconfusionQmemoryQloss



3.QReviewQwhatQdietaryQrecommendationsQfromQtheQcarlatQreportQareQgoodQforQmentalQhealthQpatientsQ-
QcorrectQanswerQ-eatQwholeQfoods,Qfolate,Qb12,Qb6,QomegaQ3s,QavoidQcarbs,QlessQprocessedQfoods




4.QReviewQwhichQisQtheQslowestQdeliveryQmethodQofQmedicationsQavailableQ-QcorrectQanswerQ-byQmouth-
QoralQfastest-iv




5.QReviewQtheQmostQcommonQsideQeffectsQregardingQlongQtermQlithiumQuseQ-QcorrectQanswerQ-
kidneyQimpairmentQandQthyroid,monitorQkidenyQfunctionQtestQandQthyroidQtest



6.QReviewQtheQmechanismQofQactionQofQclonidineQ&QpropranololQforQtheQtreatmentQofQanxietyQ-
QcorrectQanswerQ-lowerQheartQrate,QmuscleQtension,QphysiologicalQandQsomaticQsymptoms




7.QReviewQpsychotropicQuseQduringQlactationQpost-
partumQregardingQonsetQrelapseQandQrecurrenceQofQmentalQdisordersQ-QcorrectQanswerQ-
notQfdaQapprovedQandQexcretedQinQbreastQmilk,QweighQrisksQoverQbenefits,QeducateQthereQareQrisks,Qsome
QsaferQthanQothers




8.QMatchingQquestionQregardingQlabsQrequiredQforQquetiapinQvalproicQacidQ&QlithiumQ-QcorrectQanswerQ-
seroquel:Qglucose,QlipidQprofile,QbnpQdepakote:Qplts,QliverQfunction,QandQplasmaQlithium:Qthyroid,Qkidney,Q
andQplasma

, 9.QReviewQtheQbestQdescriptionQofQtheQmentalQstatusQexaminationQ-QcorrectQanswerQ-
determinationQofQcognitiveQfunctionQatQtimeQofQassessment



10.QReviewQsymptomsQofQhyponatremiaQ-QcorrectQanswerQ-delerium,Qlethargy,Qnausea



11.QReviewQtardiveQdyskinesiaQ-QcorrectQanswerQ-
movemntsQcan'tQcontrol,QjawQthrusting,QtongueQmovement,QpillQrolling,Qhyperreflexex,QlotsQofQblinkingQse
enQinQantipsychotic



12.QReviewQsubstanceQdependenceQandQaQpatientsQvulnerabilityQtoQcravingQ&QrelapseQfollowingQexposure
QtoQanyQpsychoactiveQsubstance.Q-QcorrectQanswerQ-

don'tQprescribeQcontrolledQsubstancesQtoQthoseQwhoQhaveQaQsubstanceQabuseQhistoryQ.QStimulatesQelevat
edQlevelQofQdopamine.



13.QReviewQwhenQsafetyQshouldQbeQassessedQinQpsychiatricQcareQ-QcorrectQanswerQ-allQtheQtime



14.QReviewQtheQtimeQperiodQofQgreatestQriskQofQteratogenicityQinQpregnancyQ-QcorrectQanswerQ-
firstQtrimester.....beforeQknowQpregnantQ<Q8Qweeks.QNeuralQdevelopmentQisQtakingQplace



15.QReviewQdrugQchoicesQforQtaperingQofQbenzodiazepinesQ-QcorrectQanswerQ-
toQlongQacting:Qklonopin,Qvalium



16.QReviewQtheQuseQofQst.QJohnsQwartQasQanQadjunctQtoQssri'sQmedicationsQgoodQorQnotQgoodQthatQisQtheQq
uestionQ-QcorrectQanswerQ-notQgood.....increasesQserotonin



17.QReviewQtheQrecommendationQregardingQtheQuseQofQatypicalQantipsychoticsQforQtreatingQdementiaQ-
QcorrectQanswerQ-blackQboxQwarning:QincreasedQriskQforQcvQproblemsQcanQincreaseQagitation




18.QReviewQwhatQnootropicsQareQ-QcorrectQanswerQ-
neuroenhancersQnotQdrugs.QSupplementsQandQotherQsubstancesQthatQcanQenhanceQcognition,Qmemory,Q
motivation